Fuhan Yang received her BS in Biological Sciences (Honors Program) from China Agricultural University (Beijing) and MS in Neuroscience from University of the Chinese Academy of Sciences. Fuhan started her PhD at Penn State in neuroscience, and decided in 2020 to switch to epidemiology and infectious disease dynamics. She will work on the dynamics of influenza, influenza-like illness, and other respiratory diseases in tropical countries. One of her key questions will be looking at the competition among respiratory viruses in a data set from Ho Chi Minh City.
Venitha Bernard received her BSc in Zoology and Advanced Biotechnology from Women’s Christian College and MSc in Bioinformatics from Stella Maris College, both affiliated with the University of Madras, Chennai. In 2022, she started her PhD in Bioinformatics and Genomics at Penn State’s Huck Institute for the Life Sciences. At the Boni Lab, she will be studying the genetics and evolution of artemisinin resistance in P. falciparum.
Carter Farinha joined the lab in summer of 2022 and received his BS in Biology from Penn State in Spring 2023. He is working on aggregating data on antimalarial therapeutic efficacy studies and molecular markers for drug resistance into a comprehensive database.
Alexis Delabouglise was a postdoc in our lab from February 2017 to August 2019. Alexis worked on both theory and data in the economic epidemiology of avian influenza outbreaks. His game theory work showed that vaccination and depopulation behavior can fix in animal disease systems as a means of infection control; depopulation is not allowed in human disease systems and vaccination behavior cannot fix through private market incentives alone. Alexis also analyzed flock-level data (N=1087 flocks) from >50 farms in Vietnam, and was able to show that farmers do indeed depopulate their farms early when outbreaks are occurring. Alexis is currently a researcher and health economist at CIRAD in Montpellier.
Zhewen Li (Eric) received his BS in Computer Science in 2020 from the Pennsylvania State University. Eric joined the Boni Lab in Spring 2019, and focused on making computational advances in an individual-based epidemiological microsimulation to generate long-term forecasts for drug-resistance evolution in malaria. Using this model Eric evaluated what kinds of population-level treatment strategies generated the most/least risk in terms of generating novel multi-drug resistant genotypes. Eric started a Masters program at Cornell Tech in Health Technology in Fall 2020.
Sarah Vo received her BS in Biology from Penn State (Shreyer Honors College) in Spring 2021. She joined the lab in Spring 2020 to work on her undergraduate thesis. Her research was focused on generating estimates for the efficacy of artemisinin combination therapies on different genotypes of Plasmodium falciparum.
Haojun Li received his BS in Computer Science in 2021 from Pennsylvania State University. Haojun joined the lab in Spring 2020 and worked under the supervision of Dr. Robert Zupko on improving the functionality and user-friendliness of the spatial/ArcGIS database that underlies our malaria simulation.
Pakhi Agarwal received her Master of Science from Penn State in 2019 and worked in the Boni Lab in 2020 and 2021 developing unit tests for our individual-based malaria simulation.
Deborah Grace received her BS in Biology in 2023 from Pennsylvania State University. Deborah worked in the Boni Lab in 2022 and 2023 as an undergraduate research assistant and provided invaluable help to Robert Zupko in assembling malaria data for Uganda — one of the first places where artemisinin resistance was detected in Africa.
Thư Tran received her BS in Computer Science from University of Science and Technology of Hanoi and her Masters in Software Engineering from the University of Bordeaux. Thu worked at the Oxford University Clinical Research Unit from 2014 to 2017, and in the Boni Lab at Penn State where she defended her PhD in May 2023. Thư developed a genotype-phenotype map for antimalarial drug-resistance loci in P. falciparum (here) that was used in a number of key international collaborations, including one on the effect that partner-drug resistance has on artemisinin resistance evolution and another on the population-level benefits of triple therapies. During the COVID-19 pandemic, Thư devoted substantial time to model development and led two major analyses on vaccination policy during the early 2021 vaccine rollout and the evolving population immunity landscape during this rollout. In summer 2023, Thư started a position as a data scientist at Axtria.